Header Logo

Connection

JOHN KIRKWOOD to Radiation-Protective Agents

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Radiation-Protective Agents.
JOHN KIRKWOOD
Connection Strength
0.014
Radiation-Protective Agents
  1. Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686). Melanoma Res. 2003 Dec; 13(6):619-26.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.